warnings
WARNINGS KEEP OUT OF REACH OF CHILDREN If swallowed seek medical help or contact Poison Control Center immediately.
Minnerva II
openFDA label record#
This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.
Verified complete openFDA source JSON
- Brand name
- Minnerva II
- Generic name
- LIDOCAINE, EPINEPHRINE
- Manufacturer
- SofTap Inc
- Product type
- HUMAN OTC DRUG
- SPL set ID
- ddd34237-7770-19b3-e053-2995a90af775
- SPL ID
- de4a096f-33d4-35f1-e053-2a95a90a8ee7
- Version
- 2
- Effective date
- 2022-05-05
- Source export date
- 2026-09-28
- Source partition
- 6
- Source file
- https://download.open.fda.gov/drug/label/drug-label-0006-of-0014.json.zip
- Source object key
- raw/openfda/drug-label/2026-09-28/e0861bcde1444ef952820955caafc6f3fd29783e5ade07a13d933aa3336b399f/drug-label-0006-of-0014.json.zip
- Source manifest SHA-256
- cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
- Import run
- 20260929T050834Z
- Imported at
- 2026-09-29 05:42:53
| Harmonized routes |
|---|
| TOPICAL |
Harmonized identifier links#
Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.
| Type | Scope | Identifier | Source field |
|---|---|---|---|
| brand name | Minnerva II | openfda.brand_name | |
| generic name | LIDOCAINE, EPINEPHRINE | openfda.generic_name | |
| manufacturer name | SofTap Inc | openfda.manufacturer_name | |
| ndc | package | 82718-2210-1 | openfda.package_ndc |
| ndc | product | 82718-2210 | openfda.product_ndc |
| ndc11 | package | 82718221001 | derived:openfda.package_ndc |
| spl id | de4a096f-33d4-35f1-e053-2a95a90a8ee7 | id | |
| spl set id | ddd34237-7770-19b3-e053-2995a90af775 | set_id | |
| unii | 98PI200987 | openfda.unii | |
| unii | WBB047OO38 | openfda.unii |
Warnings cross-check#
openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.